Track topics on Twitter Track topics that are important to you
Hormonal contraception is a birth control method that acts on the endocrine system. Several types of female hormones are used to prevent ovulation and avoid fertilization. Hormonal contraception also results in changes in the uterus making it unlikely to develop pregnancy.
Globally, increase in adoption of hormonal contraception for birth control, rise in female population on a global level and implementation of temporary and low cost contraceptive practices instead of permanent contraception are the prime growth drivers of hormonal contraception. The major opportunities for the growth of this market are urbanization and increased consciousness about hormonal contraception and the policies setup by the governments to promote hormonal contraception. However, adverse side effects related to the use of hormonal contraceptives is the key restraint for the hormonal contraception market.
This report identifies the global hormonal contraception market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to hormonal contraception market.
Geographically, Asia Pacific dominated global hormonal contraception market, and is projected to have fastest growth, owing to growing population in this region on a global level.
This report segments global hormonal contraception market on the basis of hormone, by method, by enduse and regional market as follows:
Hormonal Contraception Market, by hormone: Androgens, Estrogens, Progestrogens, Gonadotropins and Antiandrogens
Hormonal Contraception Market, by method: Combined Oral, Oral Pill, Implanted, Injected, Intrauterine and Transdermal Patch
Hormonal Contraception Market, by enduse: Hospital, Clinics, Gynaecology Centers and Others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region. The major countries considered under the AsiaPacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico.
This report identifies all the major companies operating in the hormonal contraception market. Some of the major companies' profiles in detail are as follows:
Bayer Pharma AG
Merck Co., Inc.
Agile Therapeutics, Inc.
Teva Pharmaceutical Industries Limited
Lupin Pharmaceuticals, Inc.
Original Article: Hormonal Contraception Market: By Hormone Androgens, Estrogens, Progestrogens, Gonadotropins, Antiandrogens; By Method Combined Oral, Oral Pill, Implanted, Injected, Intrauterine, Transdermal Patch; By EndUse and By RegionForecast 20162021 [Updated: 03032NEXT ARTICLE
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...